Delivery Order SPE2D020D0005-SPE2D324F251L
Award Date
9/9/24
Potential Completion Date
9/12/24
Potential Value
$4.7K
Federal Agency
Medical Supply Chain
Awardee
Chartwell RX LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024.
Chartwell RX LLC is the prime contractor for this award,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024.
Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The delivery order is valued at $5,922.50 and has a completion date of June 7, 2024.
Chartwell RX LLC is the prime contractor and does not have any noted subcontractors. This contract is not set aside for any...
This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of 30-count packages of 8 mg ondansetron orally disintegrating tablets. Awarded by the Defense Logistics Agency (DLA) Troop Support Medical, this $3,946.20 firm fixed price delivery order does not have a set-aside designation. It is part of a larger $7 million-plus single-award indefinite delivery vehicle (IDV) contract held by Chartwell with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract (SPE2D020D0005|SPE2D324F182T) to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The $2,842.80 Firm Fixed Price contract is for the delivery of 4565371887 - Ondansetron ODT 4 mg Tablets, 30-count. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between Chartwell RX and DLA Troop Support Medical, valued at over $7 million and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, with a ceiling value of $3,946.20, is for the supply of 4564484842 ! ONDANSETRON ODT 8 MG TABLET 30S, an antiemetic medication.
The award is not associated with a set-aside program and is a firm fixed-price contract with a completion date of May 8, 2024. Chartwell...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The order, valued at $2,842.80, is for the supply of ondansetron orally disintegrating tablets (4 mg, 30-count) to support healthcare services for military personnel, veterans, and other government beneficiaries.
Chartwell RX has two significant Indefinite Delivery Vehicles (IDVs) that facilitate its work with federal agencies....
The federal contract award SPE2D020D0005|SPE2D324F8252 was granted to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The $1,302.95 fixed-price delivery order contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,273,639 units of the medication ondansetron ODT 4 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at over $7 million and running through March 2030, which allows Chartwell RX to...
This federal contract award is for the delivery of ondansetron 8 mg orally disintegrating tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, on July 3, 2024. The fixed-price delivery order contract has a ceiling value of $19,731.00 and is set to expire on July 9, 2024.
Chartwell RX is the prime contractor for this award and has established itself as a reliable supplier of both...
This is a delivery order awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,724.35 firm-fixed-price contract is for the delivery of ondansetron orally disintegrating tablets (ODT) 4 mg, with a completion date of July 25, 2024.
Chartwell RX LLC is a for-profit organization registered in the System for Award Management (SAM) that specializes in providing a wide range of branded and generic...